Bayer shares soar 11% after key U.S. legal win against Roundup cancer claims

Home » Blog » Bayer shares soar 11% after key U.S. legal win against Roundup cancer claims

August 17, 2024August 17, 2024

Bayer shares rose as the company said it scored a legal victory in its suit over claims that exposure to its popular Roundup weed killer led to cancer.

Previous PostBook Review: Risks and ReturnsNext PostUAW president slams Stellantis CEO over job cuts, alleged price gouging

Latest Articles

How Elon Musk’s plan to slash government agencies and regulation may benefit his empire
Why X’s new terms of service are driving some users to leave Elon Musk’s platform
The Pentagon’s battle inside the U.S. for control of a new Cyber Force
Top 10 S&P 500 stock winners since Election Day
Donald Trump chooses hedge fund executive Scott Bessent for Treasury secretary
Amazon to invest another $4 billion in Anthropic, OpenAI’s biggest rival
Indonesia wants Apple to sweeten its $100 million proposal as tech giant lobbies for iPhone 16 sales
One of the world’s richest families plans to create Paris’s next big soccer success
U.S. embassy in London reopens after suspicious ‘hoax’ item found
Apple and Google could face a competition probe over their huge mobile ecosystems in the UK

Advertising

GTR provides global news on topics ranging from world markets, investing opportunities, industry analysis and so much more.

News

Finance
Investments
Technology

Countries

Worldwide
Africa
Asia
Australia
Canada
Europe
United States

Official

Magazines
Videos
About Us
Contact Us
Privacy
Terms & Conditions